Lifeward launches ReWalk 7 Personal Exoskeleton for U.S. market

Lifeward Ltd.

ReWalk 7 now available nationwide for individuals with spinal cord injury.
New features: cloud connectivity, customizable speeds, crutch control, smartwatch app.
FDA clearance received in March 2025; CMS Medicare reimbursement pathway established in 2024.
Device tested with over two dozen users and therapists pre-launch.
Improved battery and stair/curb navigation enhance real-world usability.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.